Dr. Kalimuthu Karuppanan
Sai University, SRM Institute of Science and Technology, KTR, Chennai, India, University of Oxford
0000-0002-2696-8437
About
Dr. Kalimuthu Karuppanan is a protein biochemist with over eight years of international research experience and three years of teaching. He earned his Ph.D. in Biotechnology from Madurai Kamaraj University, India, and completed postdoctoral training at the Department of Chemical Engineering University of California, Davis, USA, and the Radcliffe department of Medicine, Oxford University, UK. He also worked as a Research Assistant professor at School of Bioengineering, SRM Institute of Science and Technology, Chennai India.
His research focuses on therapeutic protein and peptide engineering for infectious and metabolic diseases. He contributed to the development of the Ebola therapeutic ZMapp (emergency use authorization), also SARS-CoV-2 and Anthrax. Establishment of the Center for the Utilization of Biological Engineering in Space (CUBES), funded by NASA. He led the Pharmaceutical Division at CUBES, developing orally deliverable biotherapeutics for space health applications.
Dr. Karuppanan holds a U.S. patent on next-generation therapeutics for lung inflammation. His expertise spans immunoinformatics, glycoinformatics, and chemoinformatics. He currently serves as an Assistant Professor of Biological Sciences at Sai University, Chennai, India.
Employment
-
Sai University Assistant Professor2025 - Present
-
SRM Institute of Science and Technology, KTR, Chennai, India Assistant Professor (Research)2022 - 2024
-
University of Oxford Postdoctoral Researcher2019 - 2022
-
University of California Davis Postdoctoral Scholar2014 - 2018
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (21)
- Comprehensive Insights into Monkeypox (mpox): Recent Advances in Epidemiology, Diagnostic Approaches and Therapeutic Strategies Save
- DTBV: A Deep Transfer-Based Bone Cancer Diagnosis System Using VGG16 Feature Extraction Save
- Human monkeypox outbreak in 2022 Save
- Omicron (BA.1) and sub‐variants (BA.1.1, BA.2, and BA.3) of SARS‐CoV‐2 spike infectivity and pathogenicity: A comparative sequence and structural‐based computational assessment Save
- Affinity Sedimentation and Magnetic Separation With Plant-Made Immunosorbent Nanoparticles for Therapeutic Protein Purification Save
- Omicron and Delta variant of SARS‐CoV‐2: A comparative computational study of spike protein Save
- Omicron and Delta Variant of SARS-CoV-2: A Comparative Computational Study of Spike protein Save
- Identification of COVID-19 and COPD common key genes and pathways using a protein-protein interaction approach Save
- Molecular pharming to support human life on the moon, mars, and beyond Save
- Identification of common key genes and pathways between Covid-19 and lung cancer by using protein-protein interaction network analysis Save